BUCHI Announces New Location in Spain
Recently the BUCHI Corporation announced a new expansion into Spain, with the establishment of BUCHI Ibérica S.L. in Barcelona.
BUCHI Corporation has announced a new expansion into Spain, with the establishment of BUCHI Ibérica S.L. in Barcelona. According to the company, direct and close customer support has always been a focus of theirs so they wanted to expand their direct distribution network to cover the Spanish market. The new organization will build on the 25 years of experience their current exclusive distributor, Massó Analítica S.A., has built up. BUCHI plans for a smooth transition, with their team from Massó Analítica transitioning to the new BUCHI market organization.
The new organization will be in place January 1, 2021, and will take over all current projects and activities related to BUCHI products and services from Massó Analítica S.A.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
